Huawei plans for more AI pharma tie-ups, says healthcare president
The move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are investing in modelling tools and automated laboratories to shorten development timelines and improve efficiency.
We haven't written up this one. Economic Times Tech has the full story — the link below goes straight to it.